Diagnosis, prophylaxis, and treatment of headaches in the athlete

Southern Medical Journal

Volumn 90, Issue 9, 1997, Pages 878-888

  Swain, Randall A ^a,b   Kaplan, Barbara ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTALBITAL; BUTALBITAL PLUS CAFFEINE PLUS PARACETAMOL; BUTORPHANOL; BUTORPHANOL TARTRATE; CAPSAICIN; CYPROHEPTADINE; DANAZOL; DIHYDROERGOTAMINE; DIHYDROERGOTAMINE MESILATE; ERGOTAMINE TARTRATE; ISOMETHEPTENE MUCATE; KETOROLAC; LITHIUM CARBONATE; METHYSERGIDE MALEATE; METOCLOPRAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; PROCHLORPERAZINE MALEATE; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SUMATRIPTAN SUCCINATE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VALPROIC ACID; VERAPAMIL;

ATHLETE; CLUSTER HEADACHE; DROWSINESS; FIBROSIS; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HIRSUTISM; HUMAN; INJECTION PAIN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY INJURY; LEG PAIN; MIGRAINE; NOSE IRRITATION; ORAL DRUG ADMINISTRATION; ORTHOSTATIC HYPOTENSION; PRACTICE GUIDELINE; PRURITUS; RECTAL DRUG ADMINISTRATION; REVIEW; SUBLINGUAL DRUG ADMINISTRATION; TENSION HEADACHE; TOPICAL DRUG ADMINISTRATION; TREMOR; VERTIGO; XEROSTOMIA;

EID: 0030846822     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-199709000-00003     Document Type: Review

References (52)

1. Rasmussen BK, Jensen R, Schroll M, et al: Epidemiology of headache in a general population - a prevalence study. J Clin Epidemiol 1991;44:1147-1157
2. Illness Disability Statistics Bureau, Centers for Disease Control and Prevention: Prevalence of chronic migraine headaches - United States, 1980-1989. MMWR 1991; 40:331-338
3. Stewart WF, Lipton RB, Celentano DD, et al: Prevalence of migraine headaches in the United States. relation to age, income, race, and other sociodemographic factors. JAMA 1992; 267:64-69
4. Solbach P, Sargent J, Coyne L: Menstrual migraine headache: results of a controlled, experimental, outcome study of non-drug treatment. Headache 1984; 24:75-78
5. Edelson RN: Menstrual migraine and other hormonal aspects of migraine. Headache 1985; 25:376-379
6. Swanson JW, Yanagihara T, Stang PE, et al: Incidence of cluster headaches: a population-based study in Olmstead County, Minnesota. Neurology 1994; 44:433-437
7. Buckley M, Brogden R: Ketorolac: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 1990; 39:86-109
8. Walker RJ, Fawcett JP, Flannery EM, et al: Indomethacin potentiates exercise-induced reduction in renal hemodynamics in athletes. Med Sci Sports Exerc 1994; 26:1302-1306
9. Darling M: Exercise and migraine. J Sports Med Phys Fitness 1991; 31:294-302
10. Tek DS, McClellan DS, Olshaker JS, et al: A prospective, double-blind study of metoclopramide hydrochloride for the control of migraine in the emergency department. Ann Emerg Med 1990; 19:1083-1087
11. Jones EB, Gonzaes ER, Boggs JG, et al: Safety and efficacy of rectal prochlorperazine for the treatment of migraine in the emergency department. Ann Emerg Med 1994; 24:237-241
12. Galer BS, Lipton RB, Solomon S, et al: Myocardial ischemia related to ergot alkaloids: a case report and literature review. Headache 1991; 31:446-450
13. Peroutka S: 5-Hydroxytryptamine receptor subtypes. Ann Rev Neurosci 1988; 11:45
14. Belgrade MJ, Ling FJ, Schleevogt MB, et al: Comparison of a single dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache. Neurology 1989; 39:590-592
15. Saadah HA: Abortive headache therapy with intramuscular dihydroergotamine. Headache 1992; 32:18-20
16. Klapper JA, Stanton J: Clinical experience with patient administered subcutaneous dihydroergotamine mesylate in refractory headaches. Headache 1992; 32:21-23
17. Winner P, Ricalde O, Le Force B, et al: A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine. Arch Neurol 1996; 53:180-184
18. Ziegler D, Ford R, Krigler J, et al: Dihydroergotamine nasal spray for the acute treatment of migraine. Neurology 1994; 44:447-453
19. The Dihydroergotamine Nasal Spray Multicenter Investigators: Efficacy, safety, and tolerability of dihydroergotamine nasal spray as monotherapy in the treatment of acute migraine. Headache 1995; 35:177-184
20. Cady RK, Wendt JK, Kirchner JR, et al: Treatment of acute migraine with subcutaneous sumatriptan. JAMA 1991; 265:2831-2835
21. Ottervanger JP, Paalman HJA, Boxma GL, et al: Transmural myocardial infarction with sumatriptan. Lancet 1993; 341:861-862
22. Luman W, Gray RS: Adverse reactions associated with sumatriptan. Lancet 1993; 341:1091-1092
23. The Multi-national Oral Sumatriptan and Cafergot Comparative Study Group: A randomized, double-blind comparison of sumatriptan and cafergot in the acute treatment of migraine. Eur NeurOl 1991; 31:314-322
24. The Oral Sumatriptan and Aspirin Plus Metoclopramide Comparative Study Group: A study to compare oral sumatriptan plus metoclopramide in the acute treatment of migraine. Eur Neurol 1991; 32:1277-1284
25. Solbach MP, Waymer RS: Treatment of menstruation-associated migraine headache with subcutaneous sumatriptan. Obstet Gynecol 1993; 82:769-772
26. Kudrow L, Kudrow DB, Sandweiss, MA: Rapid and sustained relief of migraine attacks with intranasal lidocaine: preliminary findings. Headache 1995; 35:79-82
27. Kaplan NM, Alderman MH, Flamenbaum W, et al: Guidelines for treatment of hypertension. Am J Hypertens 1989; 2:75-79
28. Holroyd KA, Penzien DB, Cordingley GE: Propranolol in the management of recurrent migraine: a meta-analytic review. Headache 1991; 31:333-340
29. Markley HG, Cheronis JSC, Piepho RW: Verapamil in prophylactic use for migraine. Neurology 1984; 34:973-976
30. Solomon GD, Steel JG, Spaccavento FJ: Verapamil prophylaxis of migraine: a double-blind, placebo-controlled study. JAMA 1983; 250:2500-2502
31. Baumel B: Migraine: a pharmacologic review with newer options and delivery modalities. Neurology 1991; 44(suppl 3):S13-S17
32. Jensen R, Brinck T, Olesen J: Sodium valproate has a prophylactic effect in migraine without aura: a triple blind, placebo-controlled crossover study. Neurology 1994: 44:647-651
33. Mathew NT, Saper JR, Silberstaein SD, et al: Migraine prophylaxis with divalproex. Arch Neurol 1995; 52:281-286
34. Lichten EM, Bennett RS, Whitty AJ, et al: Efficacy of danazol in the control of hormonal migraine. J Reprod Med 1991; 6:419-424
35. Bender WI: ACE inhibitors for prophylaxis of migraine headaches. Headache 1995; 35:470-471
36. Kudrow L: Response of cluster headaches to oxygen inhalation. Headache 1981; 21:1-4
37. Silberstein SD, Mather PJ, Schulman EA, et al: The treatment of cluster headache with repeating intravenous dihydroergotamine (IV DHE) (Abstract). Cephalalgia 1991; 11 (suppl 11):266-267
38. The Sumatriptan Cluster Headache Study Group: Treatment of acute cluster headache with sumatriptan. N Engl J Med 1991; 325:322-326
39. Monstad I, Krabbe A, Micieli G, et al: Preemptive oral treatment with sumatriptan during a cluster period. Headache 1995; 35:607-613
40. Kittrelle JP, Grouse DS, Seybold M: Cluster headache and anaesthetic abortive agents. Arch Neurol 1985; 42:496-498
41. Marks DR, Rappaport A, Padla D, et al: A double-blind placebo-controlled trial of intranasal capsaicin for cluster headache. Cephalalgia 1993; 13:114-116
42. Gabe IJ, Spierings ELH: Prophylactic treatment of cluster headache with verapamil. Headache 1989; 29:167-168
43. Hering R, Kuritzky A: Sodium valproate in the treatment of cluster headache: an open clinical trial. Cephalalgia 1989; 9:195-198
44. Powell B: Weightlifter's cephalgia. Ann Emerg Med 1982; 11:449-452
45. Kaufman A, Kaufman RS: Use of the MORA to reduce headaches on members of the US Olympic Luge Team. Basal Facts 1983; 5:129-133
46. Perstronk A, Perstronk S: Goggle migraine (Letter). N Engl J Med 1983; 308:226-227
47. Massey EW: Effort headache in runners. Headache 1982; 22:99-100
48. Lambert RW, Burnet DL: Prevention of exercise-induced migraine by quantitative warm-up. Headache 1985; 25:317-319
49. Paulson GW, Zipf RE, Beekman JF: Pheochromocytoma causing exercise-related headache and pulmonary edema. Ann Neurol 1974; 5:96-99
50. Bennett DR, Fuenning SI, Sullivan G, et al: Migraine precipitated by head trauma in athletes. Am J Sports Med 1980; 8:202-205
51. Chester JF, Conlon CP: Case reports: some cerebrovascular complications of exercise. Br J Sports Med 1983; 17:143-144
52. Saunders RL, Harbaugh RE: The second impact in catastrophic contact sports head trauma. JAMA 1984; 252:538-539